Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel C Marrs

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|February 26, 2009
Colesevelam for the management of type 2 diabetesJoel C Marrs
The Annals of Pharmacotherapy|July 3, 2008
Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomniaJoel C Marrs
The American Journal of Managed Care|January 5, 2012
Optimizing outcomes in patients with cardiovascular disease and chronic kidney diseaseJoel C Marrs
The Annals of Pharmacotherapy|October 28, 2010
Spironolactone management of resistant hypertensionJoel C Marrs
Drugs & Aging|April 26, 2012
Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HClJoel C Marrs
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 23, 2006
Family medicine pharmacy residency programsJoel C Marrs
The New England Journal of Medicine|April 2, 2015
Duration of dual antiplatelet therapy after drug-eluting stentsJoel C Marrs
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 29, 2015
Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial OutcomesAlpesh Amin, Joel C Marrs
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 14, 2022
ASHP Statement on Pharmacist Prescribing of StatinsJoel C Marrs, Cyrine-Eliana Haidar
European Endocrinology|April 11, 2018
Antihyperglycemic Medications and Cardiovascular Risk ReductionSarah L Anderson, Joel C Marrs
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Metabolism & Toxicology|February 26, 2009
Colesevelam for the management of type 2 diabetesJoel C Marrs
The Annals of Pharmacotherapy|July 3, 2008
Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomniaJoel C Marrs
The American Journal of Managed Care|January 5, 2012
Optimizing outcomes in patients with cardiovascular disease and chronic kidney diseaseJoel C Marrs
The Annals of Pharmacotherapy|October 28, 2010
Spironolactone management of resistant hypertensionJoel C Marrs
Drugs & Aging|April 26, 2012
Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HClJoel C Marrs
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 23, 2006
Family medicine pharmacy residency programsJoel C Marrs
The New England Journal of Medicine|April 2, 2015
Duration of dual antiplatelet therapy after drug-eluting stentsJoel C Marrs
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 29, 2015
Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial OutcomesAlpesh Amin, Joel C Marrs
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 14, 2022
ASHP Statement on Pharmacist Prescribing of StatinsJoel C Marrs, Cyrine-Eliana Haidar
European Endocrinology|April 11, 2018
Antihyperglycemic Medications and Cardiovascular Risk ReductionSarah L Anderson, Joel C Marrs
Pageof 7